Spc Global Holdings Ltd · ASX:SPG

Spc Global — Investor Presentation (October 2020)

38 slides from Spc Global's investor presentation, Oct 27, 2020

  1. Slide 1: Investor Presentation

    Investor Presentation Tony Rowlinson CEO and Managing Director October 2020

  2. Slide 2: Who we are

    Who we are An Australian beverage and wellness supplement company, specialising in the development of innovative health focused products for retail in Australia and Asia. Our Ambition To be a leading provider of beverages, functional foods, nutraceuticals and wellness supplements that improve the qu

  3. Slide 3: The revolution in food

    The revolution in food Shift to healthy Healthy living Obesity eating and lifestyles – concerns have consumption of exercise, diet, exploded myths more natural work/balance about sugar products Covid-19 drives Increased Formal consumer focus consumer mealtime on hygiene and choice replaced by “on he

  4. Slide 4: Markets we operate in and our share

    Markets we operate in and our share Growth

  5. Slide 5: Our product portfolio

    Our product portfolio Premium fresh juice All natural wellness Premium health & beauty OBL Superfoods & plant based Marine Collagens 100% Australian juice ingredients Australian superfood with OJC Immunity Shots Collagen Cold pressed range Wellness beverages Plant based range Adaptogen powders Quenc

  6. Slide 6: Product Capabilities

    Product Capabilities Fruit Juices Manufacturing capabilities Sports Drinks • Juice Extraction & beverage • Bottling (50m litres p.a) packaging • Functional gels, sachet, oil pressing Functional Drinks • Cold storage and distribution • Quality assurance and compliance • Technology & micro-dosing Hydr

  7. Slide 7: 2020 Financial performance

    2020 Financial performance x a

  8. Slide 8: 2020 impacts

    2020 impacts • Acquired Original Juice Co. • OJC brand relaunch delivers growth • Drought and fires impact supply by 40% • No grower contracts • Retailer service levels from 98% to 85%

  9. Slide 9: 2020 financial review

    2020 financial review FY20 Gross Gross Profit EBITDA loss Non COGs Cash Sales Margin Expenses +17% 15% $5.5m -32% $2.9m To $42m in FY20 25% in FY19 Loss of $11.6m To $10.3m in in FY19 FY20 50 37.5 25 12.5 0 2017 2018 2019 2020 Gross Sales Gross Profit

  10. Slide 10: Significant internal momentum in the past 6 months

    Significant internal momentum in the past 6 months EBITDA & SALES GROWTH CHINA ENTRY PRICE INCREASES 1st quarter turnaround, now Eridani brand has been launched Effective 14th September 2020, trading profitably and secured a $1 million order to prices with all Australian retailers supply the Chinese

  11. Slide 11: Overall strategy & delivery

    Overall strategy & delivery

  12. Slide 12: Overall strategy

    Overall strategy Build Brand Drive performance Expand into China portfolio Improvements Fast-track product Lead Player in Security of Supply roll-out Functional Foods

  13. Slide 13: Our objectives

    SALES CAGR OF 16% Our objectives DIVISIONALISE PER ANNUM OBL TO ACHIEVE 15% BUSINESS SHARE OF AUSTRALIAN IN BEST SERVICING JUICE MARKET NEW MARKETS TO BE A LEADING PROVIDER LAUNCH ERIDANI CHINA OF BEVERAGES, FUNCTIONAL ALL NATURAL HEALTH TO ACCOUNT FOR & BEAUTY BRAND FOODS, NUTRACEUTICALS AND 30% OF

  14. Slide 14: First quarter results

    First quarter results Juice sale: $9.6 million EBITDA +28% $1,5m VS P.Y ($438k)

  15. Slide 15: Orange juice & functional benefit strategy

    Orange juice & functional benefit strategy

  16. Slide 16: Orange Juice Co. Strategy

    Orange Juice Co. Strategy Leverage brand Commit to Build out loyalty, heritage remaining a offering under and trust quality brand OJC label Juice ‘Black Label’ Pressed Original Juice Seasonal Probiotic

  17. Slide 17: Orange Juice Co. growth map

    Orange Juice Co. growth map 01 New channels, Expand into new channels (3,000+ stores) wider distribution of Route current range Petrol & Convenience Export 02 Product range Product differentiation Current range and Fermented Beverages distribution On-the-go offering (2,500 stores) Better-for-you bev

  18. Slide 18: Wellness range offer

    Wellness range offer Launch a range of products containing all natural ingredients WRSURWHFW\RXULPPXQHV\VWHPDQGGHOLYHU´UHDOµIXQFWLRQDOEHQHÀWV Wellness shots Functional beverages Recover Relax Calm Immunity Antioxidant Gut health Renew Brain power Purify Antioxidant Focus Digestion Immunity Energy Dig

  19. Slide 19: All natural ingredients

    All natural ingredients GINSENG GRAPESEED IMMUNITY ANTIOXIDANTS ENERGY oer FM SPIRULINA | Focus TURMERIC | orrox FOCUS IMMUNITY DETOX oy ONG wg i * ’ GINKGO ACACIAFIBRE | COLLAGEN FOCUS DIGESTION RENEW PROBIOTICS HEMP SCR GLEE DIGESTION CALM ae THE FOOD REVOLUTION GROUP

  20. Slide 20: Launch of Juice Lab range of Wellness Shots and Beverages

    Launch of Juice Lab range of Wellness Shots and Beverages Wellness Shots Range of 9 SKU’s utilizing all natural superfoods, plant based ingredients Wellness Beverages Range of 6 SKU’s all natural, plant based ingredients

  21. Slide 21: Australian retailer plan

    Australian retailer plan • FOD now producing Coles-branded Iced Tea and • Plan to roll out Juice Lab Wellness beverages in Seasonal Juices January 2021 • Extensive ranging of Original Juice Co with over • Tendering for $5m Coles Housebrand Orange range 14 lines listed 12% Price increase • Developing

  22. Slide 22: Wellness supplements

    Wellness supplements

  23. Slide 23: The global market for collagen

    The global market for collagen FOD’s initial focus is on the collagen market, which is currently worth $4.6 billion, anticipated to exceed $6 billion by 2026. Other areas being developed include adaptogenics, fibres and plant based supplements.

  24. Slide 24: Marine Collagen range aimed at the Chinese market

    Marine Collagen range aimed at the Chinese market

  25. Slide 25: Marine Collagen range aimed at the Chinese market

    Marine Collagen range aimed at the Chinese market

  26. Slide 26: Juice Lab range of plant based wellness powders (Australia)

    Juice Lab range of plant based wellness powders (Australia)

  27. Slide 27: Chinese distribution strategy

    Chinese distribution strategy

  28. Slide 28: Extensive channel focus in China

    Extensive channel focus in China Careline/C-mart Network Utilising e-commerce platform which has 10 000 distributors today. Careline will be an active distribution channel for new products from FOD’s plant upgrade e-Commerce FOD plans to establish JD and Tmall e-commerce shops/presence Potential ver

  29. Slide 29: Driving operational efficiency

    Driving operational efficiency

  30. Slide 30: Planned activity to deliver $1.5 million in savings per annum

    Planned activity to deliver $1.5 million in savings per annum Current inefficiencies Poor fruit > $200k Conversion inefficiency > $2 million Downtime, waste, overfill > $500k PASTEURIS- PULP PASTEURIS- RECEIVING SQUEEZING BATCHING BOTTLING PACKING ATION REMOVAL ATION 1 2 OEE monitoring downtime and

  31. Slide 31: Security of supply

    Security of supply 80% of annual volume is now under contract to our growers TRANSPORT & GROWERS PACKAGING RAW MATERIALS TECHNOLOGY • Fruit and vegetable products • Packaging inputs sourced • Aus Chilli • Reliable and efficient sourced from industry- from quality manufacturers transport contractors

  32. Slide 32: Outlook

    Outlook

  33. Slide 33: 2020 and beyond

    2020 and beyond Leverage the OJC brand Position Original Juice Co. Mill Park upgrade will to maximise value from in China through boost product variety and new product development distribution partners capabilities Leverage domestic Adapt customer centric Seek juice acquisition/ partners through new

  34. Slide 34: Appendix

    Appendix

  35. Slide 35: Our strategy

    Horizon 3 Establish leadership position in wellness supplements • Launch Obtain substantial share in categories we operate in Our strategy • Extend availability into new markets • Enter new categories building off brands platforms • Progress juice acquisition/consolidation Horizon 2 Launch wellness

  36. Slide 36: Careline/Norman Li Strategic Investment

    Careline/Norman Li Strategic Investment Final Tranche of $20.25m Strategic Investment Final Performance Shares Summary Tranche 1 – 18.5 million ordinary shares, an investment of A$1,000,000, on or before 28 September 2018. Performance Milestone Shares Tranche 2 – 46.5 million ordinary shares, an inv

  37. Slide 37: Corporate snapshot

    Corporate snapshot Capital Structure Substantial Holders (as at 30 Septembet 2020) Share Price $0.045 Norman Li 35.57% Shenzhen Youngheng Market Capitalisation $32.61m 7.59% Biotechnology Co Limited Shares on Issue 724.68m Cash at bank A$1.53m

  38. Slide 38: Contact

    Contact Tony Rowlinson Craig Sainsbury CEO & Managing Director Investor Relations +61 3 9982 1451 craig.sainsbury@marketeye.com.au +61 428 550 499

Spc Global Holdings — Investor Presentation (October 2020) on 6ix